Specialty pharmacies reduce administrative burden and total cost of care as advanced therapies move to community sites, Fran ...

Pirtobrutinib plus venetoclax-rituximab reduced progression/death risk versus venetoclax-rituximab alone in R/R CLL/SLL, with higher undetectable MRD rates at 10–6. Head-to-head FLT3 inhibition in ...

For Europe to remain an attractive site for phase 3 research, he argued, regulatory predictability is paramount. El-Galaly ...

Arash Mostaghimi highlighted the scientific journey that led to Janus kinase (JAK) inhibitors becoming a treatment avenue for ...

Experts explain how longer-lasting anti-VEGF injections reduce treatment burden and improve real-world vision outcomes in AMD ...

Shannon L. Maude, MD, PhD, highlighted promising long-term disease-free survival and MRD negativity with tisagenleucel in ...

Evidence-Based Diabetes Management | Journals | The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

To mitigate this risk, the Chaparro recommends pairing pharmacologic therapy with light resistance or weight training and ...

The Medicare GLP-1 Bridge's July 1 launch is now the only concrete milestone on the calendar. Whether it becomes the ...

In the final episode, 'From Specialist Roles to Unmet Needs: Advancing Alopecia Areata Care,' the panelists explored the ...

Lin: Genomic classifiers are widely used to assess the risk of distant metastasis (DM) and inform chemotherapy (CT) decisions ...

Welcome back to another AJMC Insights series. In this episode titled, 'Setting the Stage: Treatment Selection and Eligibility ...